Home » Authors » Jennifer Boggs

Jennifer Boggs

Articles

ARTICLES

Penwest's PW2101 Receives Thumbs Down; Drug Shelved

July 1, 2005

By Jennifer Boggs

Penwest's PW2101 Receives Thumbs Down; Drug Shelved

July 1, 2005

By Jennifer Boggs

CV Therapeutics Raising $288M Via Stock, Notes

June 30, 2005

By Jennifer Boggs

CV Therapeutics Raising $288M Via Stock, Notes

June 30, 2005

By Jennifer Boggs

Cougar Adds Seocalcitol, Fattens Oncology Pipeline

June 29, 2005

By Jennifer Boggs

Cougar Adds Seocalcitol, Fattens Oncology Pipeline

June 29, 2005

By Jennifer Boggs

Metabasis Signs AMPK Deal With Merck Worth Up To $74M

June 28, 2005

By Jennifer Boggs

Metabasis Signs AMPK Deal With Merck Worth Up To $74M

June 28, 2005

By Jennifer Boggs

Salix Plans To Acquire InKine In Stock Deal Valued at $190M

June 27, 2005

By Jennifer Boggs

Salix Plans To Acquire InKine In Stock Deal Valued at $190M

June 27, 2005

By Jennifer Boggs

View All Articles by Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...